Physician profile
Maxine Vu
NPI 1558416438
$387.26
in general payments reported to CMS, 2019-2025
9 companies · $20.00 in 2025
The $20.00 reported for 2025 was less than what a typical General Practice (Dentist) provider received nationally (typical 2025 total: $74.60).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $49.42 · 2021: $19.99 · 2022: $54.00 · 2023: $111 · 2024: $133 · 2025: $20.00.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Education: $175 · Food and Beverage: $88.85.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Education | $175.00 |
| Food and Beverage | $88.85 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Straumann USA LLC | $175.00 | 2023-2024 | |
| Align Technology, INC. | $54.00 | 2022 | |
| Nobel Biocare USA | $37.40 | 2019 | |
| Ultradent Products INC | $33.07 | 2021-2023 | Opalescence |
| Dentsply Sirona INC | $22.42 | 2023 | Cavitron |
| Zimvie INC. | $20.00 | 2025 | |
| 3shape INC | $16.76 | 2024 | Trios 5 |
| Elevate Oral Care | $16.59 | 2024 | Just Right 5000, Advantage Arrest, Fluorimax 5000 |
| Orapharma, A Division of Bausch Health US, LLC | $12.02 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Maxine Vu listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.